Fortis Malar Hospitals Ltd
Fortis Malar Hospitals Ltd (FORTISMLR) last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹0.15 crore. The stock last traded at ₹40, a market capitalisation of ₹75 crore, on a P/E of 577. Over the past 52 weeks the stock has ranged between ₹39 and ₹69.7. Figures are as of 9 Oct 2026 and are not real time.
Fortis Malar Hospitals Ltd share price and key metrics
- Current price
- ₹40
- Market cap
- ₹75 cr
- Stock P/E
- 577
- Book value
- ₹18.3
- ROE
- 12.8%
- ROCE
- 14.6%
- Dividend yield
- 0.00%
- 52w high / low
- 69.7/39.0
Metrics as of 9 Oct 2026. Not real time.
Track Fortis Malar Hospitals Ltd
Cruxal reads every Fortis Malar Hospitals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Fortis Malar Hospitals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 50%
- 10 Years
- -5%
- 5 Years
- 18%
- 3 Years
- 31%
- TTM
- -97%
- 10 Years
- -7%
- 5 Years
- -10%
- 3 Years
- -11%
- 1 Year
- -42%
- 10 Years
- -5%
- 5 Years
- -8%
- 3 Years
- -2%
- Last Year
- 13%
Fortis Malar Hospitals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0 cr, down 100.0% from ₹0.02 cr a year earlier. Net profit was ₹0.15 cr, down 96.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0.02 | 0.03 | 0 | 0 | 0 |
| Expenses | 0.47 | 0.41 | 0.37 | 0.35 | 0.41 | 0.33 | 0.55 | 0.33 |
| Operating profit | -0.47 | -0.41 | -0.37 | -0.33 | -0.38 | -0.33 | -0.55 | -0.33 |
| OPM % | — | — | — | -1,650.00% | -1,266.67% | — | — | — |
| Other income | 0.56 | 0.56 | 0.77 | 4.61 | 0.52 | 0.52 | 0.66 | 0.53 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.09 | 0.15 | 0.4 | 4.28 | 0.14 | 0.19 | 0.11 | 0.2 |
| Tax % | 0.00% | 93.33% | 10.00% | 3.04% | 92.86% | 89.47% | 136.36% | 25.00% |
| Net profit | 0.09 | 0.01 | 0.36 | 4.15 | 0.01 | 0.02 | -0.05 | 0.15 |
| EPS (₹) | 0.05 | 0.01 | 0.19 | 2.21 | 0.01 | 0.01 | -0.03 | 0.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fortis Malar Hospitals Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 141 | 149 | 145 | 112 | 69.24 | 86.18 | 85.95 | 59.01 | 0 | 0 | 0.03 |
| Operating profit | 0.92 | 1.75 | -2.35 | -2.7 | -6.34 | 3.44 | 4.57 | -1.21 | -2.14 | -1.62 | -1.59 |
| OPM % | 0.65% | 1.17% | -1.63% | -2.41% | -9.16% | 3.99% | 5.32% | -2.05% | — | -3,140.00% | -5,300.00% |
| Net profit | 3.11 | 3.32 | 2.06 | -8.89 | -7.87 | -8.27 | -15.48 | 45.32 | 0.39 | 4.14 | 0.13 |
| EPS (₹) | 1.67 | 1.78 | 1.10 | -4.74 | -4.20 | -4.41 | -8.26 | 24.18 | 0.21 | 2.21 | 0.07 |
TTM is the trailing twelve months to the most recent quarter.
Fortis Malar Hospitals Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 18.68 | 18.70 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
| Reserves | 80.87 | 84.35 | 86.62 | 77.65 | 69.99 | 61.37 | 45.42 | 90.71 | 11.45 | 15.59 |
| Borrowings | 0.00 | 0.00 | 0.00 | 64.34 | 57.17 | 53.41 | 46.40 | 0.00 | 0.00 | 0.00 |
| Other liabilities | 31.14 | 46.03 | 45.46 | 32.80 | 23.18 | 27.37 | 27.42 | 6.41 | 6.62 | 3.26 |
| Total liabilities | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 | 37.61 |
| Fixed assets | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 105.49 | 124.57 | 128.26 | 112.38 | 100.22 | 103.23 | 90.59 | 115.88 | 36.83 | 37.61 |
| Total assets | 130.69 | 149.08 | 150.84 | 193.55 | 169.10 | 160.91 | 138.00 | 115.88 | 36.83 | 37.61 |
As reported by the company. Total assets equal total liabilities by construction.
Fortis Malar Hospitals Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -8.58 | 8.79 | -15.97 | -0.30 | -0.86 | 6.84 | 5.61 | -7.30 | 1.54 | 0.62 |
| Cash from investing | 13.47 | -1.56 | 6.34 | 49.88 | -27.51 | 8.23 | 0.50 | 119.70 | -29.10 | 0.46 |
| Cash from financing | -0.97 | 0.05 | 0.15 | -11.57 | -7.25 | -10.10 | -12.65 | -10.85 | -79.65 | 0.00 |
| Net cash flow | 3.92 | 7.28 | -9.48 | 38.01 | -35.62 | 4.98 | -6.54 | 101.55 | -107.21 | 1.08 |
| Free cash flow | -12.14 | 5.11 | -18.68 | -3.20 | -1.39 | 5.56 | 3.73 | -9.60 | 1.54 | 0.62 |
| CFO / operating profit | -175% | 801% | 458% | -143% | 204% | 220% | 121% | 188% | 81% | 51% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Fortis Malar Hospitals Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 5.02% | 5.90% | 3.24% | -3.04% | -7.15% | -1.25% | -0.77% | -3.29% | 0.83% | 14.65% |
| Debtor days | 14.49 | 14.68 | 24.39 | 12.17 | 11.02 | 9.32 | 13.50 | 0.00 | — | — |
| Inventory days | 28.37 | 22.30 | 18.04 | 22.44 | 42.32 | 39.89 | 31.71 | 0.00 | — | — |
| Days payable | 173.78 | 277.45 | 257.22 | 323.72 | 373.05 | 428.91 | 584.69 | — | — | — |
| Cash conversion cycle | -130.92 | -240.47 | -214.79 | -289.11 | -319.72 | -379.70 | -539.47 | 0.00 | — | — |
| Working capital days | 152.64 | 131.84 | 155.53 | -55.01 | 114.55 | 21.60 | 183.80 | -8.35 | — | — |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Fortis Malar Hospitals Ltd shareholding pattern
Promoters held 62.71% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.07%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% |
| DIIs | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Public | 37.22% | 37.22% | 37.23% | 37.24% | 37.21% | 37.21% | 37.22% | 37.22% |
| No. of shareholders | 18,860 | 21,547 | 26,918 | 27,832 | 27,644 | 27,022 | 26,259 | 25,734 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Fortis Malar Hospitals Ltd corporate filings
- The relevant disclosure is attachedCompany Updatelow impact
- The relevant disclosure is attached.Insider Trading / SASTlow impact
- Fortis Malar Hospitals Ltd: Routine Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: Fortis Malar Hospitals Ltd has published a statutory notice in newspapers regarding its…
Read the full analysis - Fortis Malar Hospitals Reports Q1 FY27 Profit Amidst Business Cessation and Restructuring Uncertainty; Cash Position StrongResulthigh impact
Cruxal's analysis: Fortis Malar Hospitals Limited has reported a standalone Profit After Tax (PAT) of INR…
Read the full analysis - Approval of Financial Results for the quarter ended June 30, 2026Board Meetingmedium impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.